Do CGMs Actually Benefit Non-Diabetics? What the Science Says

Continuous glucose monitors (CGMs), originally developed for people with type 1 diabetes, are increasingly marketed to the general public as wellness devices. However, a new review prepared at the request of JAMA Internal Medicine finds no scientific evidence that these monitors improve health outcomes or prevent disease in individuals without diabetes. While the technology helps some patients with type 2 diabetes adjust treatments and reduce the necessity of finger-stick tests, researchers warn that widespread adoption among healthy populations risks misinterpreting normal physiological fluctuations and straining healthcare resources.

Clinical Utility vs. Consumer Wellness

For patients diagnosed with diabetes, the clinical value of continuous glucose monitoring is well-documented. According to the review, CGM use is associated with a modest reduction in HbA1c levels for those with type 2 diabetes. By providing real-time data, these devices allow for more precise treatment adjustments and offer a benefit for individuals at high risk of hypoglycemia, or low blood sugar, by reducing the frequency of manual finger-stick testing.

The landscape shifts, however, when the technology is applied to healthy individuals. Minna Johansson, an Associate Professor at the Sahlgrenska Academy, University of Gothenburg and a general practitioner at Herrestads Primary Care Center, notes that there is simply no evidence of health benefits for this group. Johansson argues that companies marketing these devices to the public should be more transparent regarding the lack of scientific data supporting their use for health optimization in non-diabetic populations.

The Risk of Over-Interpretation

A primary concern for medical professionals is the potential for healthy users to misread their own data. Because CGMs generate enormous amounts of information, normal, healthy variations in blood glucose levels may be misinterpreted. This can lead to unnecessary anxiety and the adoption of restrictive, potentially unhealthy dietary habits.

Johansson highlights a growing trend where healthy individuals seek medical care to interpret their CGM readings. This creates an unintended burden on the medical system. “If the use continues to increase, it risks drawing time and resources away from patients with greater healthcare needs,” Johansson states. The researchers emphasize that medical technology should be deployed based on proven clinical value rather than mere availability or the novelty of data generation.

Future Trends in Glucose Monitoring

The JAMA Internal Medicine review, which includes a peer-reviewed Patient Page to help both the public and clinicians navigate this evidence, suggests that the future of the technology should focus on targeted medical interventions.

Frequently Asked Questions

• Do CGMs help healthy people prevent diabetes? Currently, there is no scientific evidence to support the claim that using a CGM prevents disease in people without diabetes.
• Are there risks to using a CGM if I don’t have diabetes? Yes, researchers warn that users may over-interpret normal blood glucose fluctuations, leading to unnecessary dietary restrictions and anxiety.
• Who benefits most from continuous glucose monitoring? The technology is used by people with type 1 and type 2 diabetes.

Are you considering using a continuous glucose monitor for wellness purposes, or are you a patient currently managing diabetes with this technology? Share your experiences in the comments below, or subscribe to our newsletter for more updates on evidence-based health technology.